Rigel Pharmaceuticals, Inc. Common Stock (NASDAQ: RIGL) last traded at $49.08, up 0.74% on the session. The quote above updates while this page is open; the figures below are drawn from Rigel Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Rigel Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker RIGL. Its market capitalisation is $916.81 million.
Valuation measures for Rigel Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $916.81M |
|---|---|
| Enterprise value | $951.64M |
| P/E ratio | 2.91 |
| Price / sales | 3.31 |
| Price / book | 2.16 |
| Beta |
| 0.73 |
Trailing-twelve-month figures tagged in Rigel Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $276.79M |
|---|---|
| Net income (TTM) | $321.91M |
| EPS (TTM) | $16.89 |
| Gross margin | 91.39% |
| Operating margin | 31.45% |
| Return on equity | 75.67% |
| Cash | $60.82M |
Range and volume for RIGL over the past 52 weeks.
| 52-week high | $52.24 |
|---|---|
| 52-week low | $24.95 |
| Volume | 279.4K |
| Average volume | 288.9K |
| Previous close | $48.72 |
Invest a chosen dollar amount in Rigel Pharmaceuticals, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RIGL.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.